GLP-R | Peptide Encyclopedia | Auryx
GLP-R is a physician-reviewed Auryx Learn encyclopedia entry. A triple agonist targeting GLP-1, GIP, and glucagon receptors — the most advanced metabolic peptide in its class. This page is educational. It is not a dosing guide and not a substitute for a licensed clinician.
How it works
Adding glucagon receptor agonism to dual GLP-1/GIP action increases hepatic fat oxidation and energy expenditure, producing fat loss through three distinct pathways. GLP-R addresses metabolic dysfunction at a breadth that earlier agonists cannot match.
- Highest average weight reduction observed in class (up to 24% in Phase 2)
- Liver fat reduction (potential NASH application)
- Improved metabolic flexibility
- Appetite suppression with increased caloric output
Frontier metabolic protocol for individuals seeking maximum body composition transformation under clinical supervision.
Phase 3 trials ongoing as of 2025. Not yet FDA-approved — available under physician-supervised compounding protocols.
Clinic context and next steps
Pair this entry with the matching shop listing when Auryx offers the compound, or browse the full encyclopedia. Category shopping lives under shop. Mechanism language is not a personal outcome and does not approve a protocol.
Auryx is an MD-led telemedicine clinic. Eligible patients complete remote intake; compounds ship from regulated United States compounding pharmacies after clinical review. Use the protocol finder if you are matching a goal, our method for the four-step process, and about for physician leadership. Citations sit on sources. Questions go to contact or info@auryxlife.com.
Nothing on Learn diagnoses, treats, cures, or prevents disease. Read privacy and terms before you share health information. Language homepages: español and português.